Eledon Pharmaceuticals (ELDN) Other financing activities (2014 - 2025)
Eledon Pharmaceuticals' (ELDN) quarterly Other financing activities came in at $115000.0 in Q4 2025, little changed on a QoQ basis from $115000.0 in Q1 2025.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) Other financing activities (2014 - 2025) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 6 years of Other financing activities data on file, last reported at $115000.0 in Q4 2025.
- Quarterly Other financing activities changed N/A year-over-year to $115000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $230000.0 (changed N/A YoY) and the FY2025 annual result came in at $230000.0, up 6.98% from the prior year.
- Other financing activities steadied at $115000.0 in Q4 2025, from $115000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $115000.0 in Q1 2025 to a low of $115000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 115,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2020 | 189,000.00 |
| Mar 31, 2020 | 5.19 Mn |
| Jun 30, 2017 | 2.72 Mn |
| Mar 31, 2017 | 400,000.00 |
| Mar 31, 2016 | 37,000.00 |
| Dec 31, 2015 | 48,000.00 |
| Sep 30, 2015 | 188,000.00 |
| Jun 30, 2015 | 207,000.00 |
| Mar 31, 2015 | 21,000.00 |
| Dec 31, 2014 | 7.53 Mn |
| Sep 30, 2014 | 90.38 Mn |
| Jun 30, 2014 | 8,000.00 |
| Mar 31, 2014 | 4,000.00 |